Data protection Impressum

Pharma

The Institute of Life Technologies of the HES-SO Valais/Wallis has forged a five-year collaboration with Debiopharm Research & Manufacturing to develop new targeted antibody fragment vectorization technologies.

HES-SO Valais-Wallis and Debiopharm partner up to battle cancer

4 October 2023

Nagi Bioscience is at the cusp of redefining the landscape of next-generation drug discovery and chemical testing technologies, placing humane testing solutions within arm’s reach of the global scientific community.

Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing

3 October 2023

Backed by its parent company Nanobacterie's fourth-place in nanomedicine patent rankings by Marks and Clerk, AlphaOnco Swiss channels the synergy of Franco-Swiss collaboration to bring forth groundbreaking cancer treatments.

Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking

23 August 2023

EPITERNA focuses on developing therapies that can extend the healthy lifespan of companion dogs, cats, and humans.

Longevity start-up EPITERNA raises EUR 10 million to slow ageing and extend lifespan

7 August 2023

This agreement will ease trade of medicines with the United States and reduce the administrative burden for the industry.

Switzerland and USA implement mutual recognition agreement to streamline pharmaceutical trade

31 July 2023

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (April-June 2023)

3 July 2023

Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey

12 June 2023

Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp

7 June 2023

Swiss Biotech Center: innovative solutions for biopharmaceutical development

1 … 6 7 8 9 10